central

Exclusive: Russia expects to recover far less from 'bad bank' assets – sources

Russia will dramatically cut its estimate of the sum it expects to recover from a “bad bank” set up after the collapse of three major lenders, according to three sources familiar with new calculations being prepared for the central bank

Here is the original: 
Exclusive: Russia expects to recover far less from 'bad bank' assets – sources

central

Fed lifts rates, sees faster pace of hikes in Trump’s first year

The U.S. Federal Reserve raised interest rates on Wednesday and signaled a faster pace of increases in 2017 as central bankers adapted to the incoming Trump administration's promises of tax cuts, spending and deregulation. The increase in the federal funds rate to a range of between 0.50 percent and 0.75 percent was widely expected. In a news conference following the unanimous rate decision, Fed Chair Janet Yellen said Donald…

See the rest here:
Fed lifts rates, sees faster pace of hikes in Trump’s first year

central

Exclusive: Lonza in talks to buy Capsugel for more than $5 billion – sources

Swiss pharmaceutical manufacturer Lonza Group AG is in advanced talks to acquire Capsugel, a U.S. maker of capsule products and other drug delivery systems, for more than $5 billion, according to people familiar with the matter. The deal would come as Lonza seeks to boost its life sciences

Original post:
Exclusive: Lonza in talks to buy Capsugel for more than $5 billion – sources

central

Fed turns to Trump agenda with rate hike nearly in the bag

The Federal Reserve inaugurates the Trump era this week with a near-certain interest rate increase and new economic forecasts providing a first glimpse into whether the U.S. election has reshaped the central bank'…

See original here:
Fed turns to Trump agenda with rate hike nearly in the bag

central

U.S. manufacturing sector stabilizing; producer prices tame

U.S. manufacturing output increased for a second straight month in October amid gains in the production of motor vehicles and a range of other goods, suggesting that the battered factory sector was slowly recovering. The Federal Reserve said factory production rose 0.2 percent last month after a similar gain in September. Output

Continued here: 
U.S. manufacturing sector stabilizing; producer prices tame

central

Thai CPF to buy U.S. frozen-food firm Bellisio in $1.08 billion deal

BANGKOK (Reuters) – Thailand's Charoen Pokphand Foods Pcl (CPF) said it will acquire U.S. frozen-food producer Bellisio Parent LLC for $1.075 billion, paving the way for an entry into the world's

Read more here: 
Thai CPF to buy U.S. frozen-food firm Bellisio in $1.08 billion deal

central

Swire Pacific in talks to buy Coca-Cola bottling assets in China: Bloomberg

(Reuters) – Hong Kong conglomerate Swire Pacific Ltd is in talks to buy Coca-Cola Co's bottling assets in China from Cofco Corp's [CNCOF.UL] China Foods Ltd unit, Bloomberg reported. A potential deal could value the business at about $1 billion and the companies could announce a deal as soon as this week, Bloomberg said, citing people familiar with the matter. Swire…

See the original post here:
Swire Pacific in talks to buy Coca-Cola bottling assets in China: Bloomberg

central

Foreign banks shaken by Malaysia’s move to halt currency slide

By Saikat Chatterjee and Praveen Menon HONG KONG/KUALA LUMPUR (Reuters) – Foreign banks in Malaysia on Thursday were trying to work out how to comply with the central bank's clamp-down…

Read the original: 
Foreign banks shaken by Malaysia’s move to halt currency slide

central

China launches $11 billion fund for Central, Eastern Europe

China has set up a 10 billion euro ($11.15 billion) investment fund to finance projects in Central and Eastern Europe, Industrial and Commercial Bank of China said in a statement issued on Sunday. The China-Central Eastern Europe fund will

View post: 
China launches $11 billion fund for Central, Eastern Europe

central

U.S. lawmakers blast Mylan CEO over ‘sickening’ EpiPen price hikes

U.S. lawmakers on Wednesday blasted Mylan NV Chief Executive Heather Bresch for sharply increasing prices for the EpiPen emergency allergy treatment at a congressional hearing in which Republicans and Democrats questioned the reasons behind rising U.S. drug costs. The House Committee on Oversight and Government Reform called Bresch to testify in the wake of public outrage over EpiPen, whose list price has risen to $600 for a pair of the devices compared with $100 in 2007. At several points, they cut …

More here:
U.S. lawmakers blast Mylan CEO over ‘sickening’ EpiPen price hikes

Next Page »